SBC Medical Group Holdings Incorporated SBC
At closeNov 3, 2026, 4:00 PM EST
After hours · Nov 3, 4:00 PM ET
- YTD
- +20.88%
- 1 year
- +59.82%
- Market cap
- 535.83M
- Revenue (ttm)
- 217.54M
- Profit margin
- 27.55%
- EPS (ttm)
- 0.47
- Shares out
- 103.02M
- P/E ratio
- 11.09
- Forward P/E
- 0.52
- YTD return
- +20.88%
- 1-year return
- +59.82%
- Volume
- 93.84K
- Avg volume
- 196.69K
- Open
- 5.31
- Previous close
- 5.31
- Day's range
- 5.16 – 5.33
- 52-week range
- 2.78 – 5.79
- Beta
- 0.12
- Price target
- 11.00 (+111.1%)
- Earnings date
- Feb 12, 2025
2Y -1.63 (-23.94%)
Key statistics
- Enterprise value
- 620.26M
- PEG ratio
- 0.00
- Price / sales
- 2.59
- Price / book
- 0.31
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 29.50%
- Free cash flow
- 0
- Total cash
- 103.70M
- Total debt
- 29.48M
- Return on equity
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 6.77
- 200-day average
- 10.90
Analyst view
Next earnings
Feb 12, 2025
Expected Feb 12, 2025. Consensus EPS estimate 0.19.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 12, 2025 | Dec 1, 2024 | 2.41 | — | — | — |
About SBC Medical Group Holdings Incorporated
SBC Medical Group Holdings Incorporated provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and internationally. The company offers advertising and marketing services; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals and facility rentals; construction and design of franchisee clinics; medical equipment; and medical consumables procurement. It provides IT software solutions; breast augmentation, liposuction, and rejuvenation treatments, including treatment of wrinkles, acne, scars, cellulite, excess fat, discoloration, and signs of aging; laser skin toning and spot removal; eyes double fold surgery; rhinoplasty; treatment of osmidrosis and hyperhidrosis; hair transplants; gynecological formation treatments; laser hair removal; face line surgeries; cosmetical dental procedures; tattoo removal; lasik eye surgery; lateral canthoplasty; brow lift procedures; androgenetic alopecia treatment; and cheek sagging prevention methods. The company was founded in 2000 and is headquartered in Irvine, California.
- Sector
- Industrials
- Industry
- Consulting Services
- Country
- United States
- Website
- sbc-holdings.com
News
SBC Medical to Announce 3Q 2026 Financial Results SBC Medical Invests ~$3.8M In AtomicSoftware’s Series C Funding Round
SBC Medical Forms Capital and Business Alliance with AtomicSoftware, Provider of the medicalforce Clinic Management Platform Used by 800+ Clinics in Japan SBC Medical Group Commences In-House Development Of Test To Forecast Individual’s Biological Age Using DNA Methylation Analysis
SBC Medical Initiates Development of a DNA Methylation Test to Estimate Biological Age
SBC Medical Group (NASDAQ:SBC) Sets New 12-Month High Following Analyst Upgrade
SBC Medical to Participate in Several Upcoming Investor Conferences in October 2026
Analyzing UnitedHealth Group (NYSE:UNH) and SBC Medical Group (NASDAQ:SBC)
SBC Medical Group Holding Q2 2026 Earnings Call Transcript
Critical Review: 111 (NASDAQ:YI) and SBC Medical Group (NASDAQ:SBC)
Your note
Sign in to keep a note on SBC — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ZUU CO. LTD. | Beneficial Owner of more than 10% of a Class of Security | Sale | Sep 18, 2024 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Tuttle Capital Management, LLC | 0.01% | 14,369 | 78.60K | Sep 29, 2024 |
| Tower Research Capital LLC (TRC) | 0.00% | 21 | 114 | Sep 29, 2024 |
| UBS Group AG | 0.00% | 3,210 | 17.56K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity NASDAQ Composite Index Fund | 0.00% | 1,716 | 9.39K | Oct 30, 2024 |
